Skin cancer risk is modified by KIR/HLA interactions that influence the activation of natural killer immune cells

Keyphrases

• Immune Cells 100%
• Natural Killer 100%
• Killer Cell Immunoglobulin-like Receptor 100%
• Skin Cancer Risk 100%
• Basal Cell Carcinoma 62%
• Killer Cell Immunoglobulin-like Receptor Genes 50%
• Tumor 37%
• Squamous Cell Carcinoma (SqCC) 37%
• HLA-B 37%
• B Haplotype 37%
• Carcinoma Cells 25%
• HLA-C 25%
• HLA Class I Ligands 25%
• Genome-wide Association Study 12%
• Natural Killer Cells 12%
• Functional Interaction 12%
• Population-based Study 12%
• Gene Family 12%
• In Vitro Model 12%
• Selective Pressure 12%
• Cell Phenotype 12%
• Confidence Interval 12%
• Significant Risk Factors 12%
• Gene Content 12%
• Highly Polymorphic 12%
• Interaction Analysis 12%
• KIR3DS1 12%
• Multiple Basal Cell Carcinomas 12%
• Gene Content Variation 12%
• KIR2DS2 12%
• KIR2DS3 12%
• Keratinocyte Skin Cancer 12%

Immunology and Microbiology

• Immunocompetent Cell 100%
• Killer-Cell Immunoglobulin-Like Receptor 100%
• Basal Cell 33%
• Receptor Gene 33%
• P53 33%
• Squamous Cell 25%
• Haplotype 25%
• Basal Cell Carcinoma Cell 16%
• Natural Killer Cell 8%
• Genome-Wide Association Study 8%
• Upregulation 8%
• Multigene Family 8%
• Keratinocyte 8%
• In Vitro 8%

Biochemistry, Genetics and Molecular Biology

• Immunocompetent Cell 100%
• Killer-Cell Immunoglobulin-Like Receptor 100%
• Receptor Gene 33%
• P53 33%
• Haplotype 25%
• HLA-B 25%
• HLA-C 16%
• KIR2DS1 8%
• Multigene Family 8%
• Upregulation 8%
• Genome-Wide Association Study 8%
• Natural Killer Cell 8%
• Keratinocyte 8%